Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P van Rijk

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Nuklearmedizin. Nuclear Medicine|February 13, 2009
Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMPM G E H Lam, A Hoekstra, J M H de Klerk, et al.
Biological Psychiatry|October 2, 1998
Effects of meta-chlorophenylpiperazine on cerebral blood flow in obsessive-compulsive disorder and controlsK L Ho Pian, H G Westenberg, J A den Boer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1992
Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastasesJ M de Klerk, A van Dijk, A D van het Schip, et al.
Journal of the American Society of Nephrology : JASN|September 19, 1997
Pulmonary embolism after thrombolysis of hemodialysis graftsH F Smits, P P Van Rijk, J W Van Isselt, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 2, 1991
[Pheochromocytoma; current viewpoints on diagnosis and therapy]C J Lips, A Struyvenberg, H J van Rijn, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 24, 1999
[Palliative treatment of bone metastases with bone-seeking radionuclides]J M De Klerk, B A Zonnenberg, A W Huiskes, et al.
Nuclear Medicine Communications|October 26, 1999
Can bone marrow scintigraphy predict platelet toxicity after treatment with 186Re-HEDP?J M de Klerk, B A Zonnenberg, A D van Het Schip, et al.
European Journal of Nuclear Medicine|January 1, 1991
Can technetium 99m bisdiethylphosphinoethanebis-t butylisocyanide (99mTc-DEPIC) be used for routine radionuclide ventriculography?J M de Klerk, P P van Rijk, A J van Dongen, et al.
Clinical Nuclear Medicine|February 3, 2000
The long-term effects of force-transmission in an injured wrist, measured with dual-energy X-ray absorphometry: a case reportM M Hoogbergen, W Rijnders, A J Van Dongen, et al.
European Journal of Nuclear Medicine|February 5, 1999
Towards quality assurance of the sentinel node procedure in malignant melanoma patients: a single institution evaluation and a European surveyV Bongers, I H Borel Rinkes, P C Barneveld, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Nuklearmedizin. Nuclear Medicine|February 13, 2009
Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMPM G E H Lam, A Hoekstra, J M H de Klerk, et al.
Biological Psychiatry|October 2, 1998
Effects of meta-chlorophenylpiperazine on cerebral blood flow in obsessive-compulsive disorder and controlsK L Ho Pian, H G Westenberg, J A den Boer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1992
Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastasesJ M de Klerk, A van Dijk, A D van het Schip, et al.
Journal of the American Society of Nephrology : JASN|September 19, 1997
Pulmonary embolism after thrombolysis of hemodialysis graftsH F Smits, P P Van Rijk, J W Van Isselt, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 2, 1991
[Pheochromocytoma; current viewpoints on diagnosis and therapy]C J Lips, A Struyvenberg, H J van Rijn, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 24, 1999
[Palliative treatment of bone metastases with bone-seeking radionuclides]J M De Klerk, B A Zonnenberg, A W Huiskes, et al.
Nuclear Medicine Communications|October 26, 1999
Can bone marrow scintigraphy predict platelet toxicity after treatment with 186Re-HEDP?J M de Klerk, B A Zonnenberg, A D van Het Schip, et al.
European Journal of Nuclear Medicine|January 1, 1991
Can technetium 99m bisdiethylphosphinoethanebis-t butylisocyanide (99mTc-DEPIC) be used for routine radionuclide ventriculography?J M de Klerk, P P van Rijk, A J van Dongen, et al.
Clinical Nuclear Medicine|February 3, 2000
The long-term effects of force-transmission in an injured wrist, measured with dual-energy X-ray absorphometry: a case reportM M Hoogbergen, W Rijnders, A J Van Dongen, et al.
European Journal of Nuclear Medicine|February 5, 1999
Towards quality assurance of the sentinel node procedure in malignant melanoma patients: a single institution evaluation and a European surveyV Bongers, I H Borel Rinkes, P C Barneveld, et al.
Pageof 9